Brief: Oncolytics Biotech names Matt Coffey CEO
Jan 19 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* Oncolytics Biotech Inc. appoints Dr. Matt coffey to the
role of president and CEO
* Oncolytics Biotech Inc- Coffey had been serving as
company's interim president and chief executive officer since
early November 2016
Source text for Eikon: ID:nPn4wF5sca
Further company coverage: ONC.TO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Announces Clinical Supply Agreement To Evaluate Pelareorep In Combination With Loqtorzi In Squamous Cell Anal Carcinoma
Brief: Oncolytics Says Pelareorep Shows Durable Survival Benefit in Anal Cancer
Brief: Oncolytics Biotech Expects Final Cohort 4 Results Of Goblet Study In Q4 2026
Brief: Oncolytics Biotech® Secures Patent Protection To Late 2040S And Provides Intellectual Property Portfolio Update
Brief: Oncolytics Biotech® Aligns With FDA On Registrational Path For Second-Line Ras-Mutant Mss Colorectal Cancer